ATS Co. (NYSE:ATS - Get Free Report) saw a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 3,130,000 shares, an increase of 9.8% from the October 15th total of 2,850,000 shares. Approximately 3.2% of the company's shares are sold short. Based on an average daily volume of 143,600 shares, the days-to-cover ratio is presently 21.8 days.
ATS Stock Down 2.2 %
ATS stock traded down $0.62 during midday trading on Friday, hitting $28.14. The company's stock had a trading volume of 117,986 shares, compared to its average volume of 177,821. The firm has a 50-day simple moving average of $29.25 and a 200-day simple moving average of $30.19. The firm has a market capitalization of $2.76 billion, a P/E ratio of 29.31 and a beta of 1.05. The company has a quick ratio of 1.71, a current ratio of 2.08 and a debt-to-equity ratio of 1.00. ATS has a 52-week low of $24.82 and a 52-week high of $44.70.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of ATS. Van ECK Associates Corp boosted its stake in shares of ATS by 91.5% in the 2nd quarter. Van ECK Associates Corp now owns 3,294 shares of the company's stock valued at $106,000 after buying an additional 1,574 shares during the period. Bessemer Group Inc. increased its position in shares of ATS by 37.7% in the 1st quarter. Bessemer Group Inc. now owns 4,164 shares of the company's stock valued at $140,000 after purchasing an additional 1,140 shares during the last quarter. Hantz Financial Services Inc. acquired a new stake in shares of ATS in the 2nd quarter valued at $286,000. Dynasty Wealth Management LLC purchased a new stake in shares of ATS during the 1st quarter worth $337,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of ATS by 4.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 17,457 shares of the company's stock worth $565,000 after purchasing an additional 804 shares during the last quarter. 75.84% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several research analysts have recently commented on ATS shares. The Goldman Sachs Group lowered their price target on ATS from $34.00 to $30.00 and set a "sell" rating for the company in a research report on Tuesday, August 13th. JPMorgan Chase & Co. lowered their target price on ATS from $36.00 to $31.00 and set a "neutral" rating for the company in a report on Tuesday, August 13th.
Check Out Our Latest Research Report on ATS
ATS Company Profile
(
Get Free Report)
ATS Corporation, together with its subsidiaries, provides automation solutions worldwide. The company is also involved in planning, designing, building, commissioning, and servicing automated manufacturing and assembly systems, including automation products and test solutions. In addition, it offers pre-automation services comprising discovery and analysis, concept development, simulation, and total cost of ownership modelling; post automation services, including training, process optimization, preventative maintenance, emergency and on-call support, spare parts, retooling, retrofits, and equipment relocation; and contract manufacturing services, as well as after sales and services.
Featured Articles
Before you consider ATS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ATS wasn't on the list.
While ATS currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.